Kelly A Miller

Kelly A Miller is a highly experienced scientist currently serving as Principal Scientist at Generation Bio, a position held since January 2022. Previously, Kelly worked as a Senior Scientist at Glycosyn LLC from January 2018 to January 2022, where responsibilities included engineering bacterial hosts for the production of bioactive human milk oligosaccharides and achieving significant milestones for commercial fermentation trials. Kelly's experience also encompasses a tenure as a Postdoctoral Research Fellow at Massachusetts General Hospital, managing independent projects on the bacterial pathogen Shigella, and a PhD Graduate Student role at the University of Rochester Medical Center, focusing on Vibrio cholerae. Earlier experience includes critical work at Fox Chase Cancer Center, where Kelly defined cellular pathways for thyroid cancer and conducted foundational research on the p53 gene. Educational background includes a PhD and MS in Microbiology and Immunology from the University of Rochester School of Medicine and Dentistry, along with a Bachelor of Science in Cell/Cellular and Molecular Biology from the University of Connecticut.